OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 20 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 9,826,000 | $2,358,000 | 1.48% |
| SILVERBACK ASSET MANAGEMENT LLC | 12,000,000 | $3,300,000 | 1.00% |
| BVF INC/IL | 10,000,000 | $2,650,000 | 0.50% |
| Partner Investment Management, L.P. | 403,000 | $111,000 | 0.16% |
| PFM Health Sciences, LP | 16,072,000 | $4,446,000 | 0.13% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 21,414,000 | $5,934,000,000 | 0.09% |
| Verition Fund Management LLC | 2,066,000 | $547,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,653,000 | $2,943,000 | 0.05% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,000,000 | $1,623,000 | 0.02% |
| Orbimed Advisors | 5,210,000 | $1,441,000 | 0.02% |